Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Defining optimal sequencing in HCC with evidence and experience-based discussion

Date

02 Dec 2022

Session

Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Topics

Tumour Site

Hepatobiliary Cancers

Presenters

Han Chong Toh

Authors

H.C. Toh

Author affiliations

Medical Oncology Department, NCCS - National Cancer Centre Singapore, 169610 - Singapore/SG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

02 Dec 2022

Welcome and opening

Presenter: Hwai Loong Kong

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

02 Dec 2022

Current management of NSCLC in Asia Pacific

Presenter: Thanyanan Baisamut (Reungwetwattana)

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

02 Dec 2022

What’s new in the management of non-mutated NSCLC after progression to immunotherapy treatment

Presenter: Solange Peters

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

02 Dec 2022

How can we further optimize the management of RCC patients

Presenter: Marniza Binti Saad

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast

02 Dec 2022

Panel discussion and closing

Presenter: Solange Peters

Session: Ipsen - Exploring optimal management and treatment sequencing in NSCLC, HCC and RCC

Resources:

Webcast